| Sahzene Yavuz, MD | |
|
105 Desmond St, Sayre, PA 18840-2001 | |
| (201) 421-9520 | |
| Not Available |
| Full Name | Sahzene Yavuz |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 27 Years |
| Location | 105 Desmond St, Sayre, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003054248 | NPI | - | NPPES |
| 009793500 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Packer Hospital | Sayre, PA | Hospital |
| Corning Hospital | Corning, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Guthrie Medical Group Pc | 6002728656 | 612 |
| Guthrie Medical Group Pc | 6002728656 | 612 |
News Archive
ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, and PHT Corporation, the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT.
Scientists at the University of Alberta have shown that the drug remdesivir is highly effective in stopping the replication mechanism of the coronavirus that causes COVID-19, according to new research published today in the Journal of Biological Chemistry.
Perrigo Company today announced that it has acquired rights to Novel Laboratories' pending ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets), indicated for the cleansing of the colon as a preparation for colonoscopy in adults.
Population aging could peak by 2040 in Germany and by 2070 in China, according to a new study published in the journal PLOS ONE, which combines new measures of aging with probabilistic population projections from the UN. In the USA, the study shows very little population aging at all in the coming century.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
› Verified 4 days ago
| Entity Name | Guthrie Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134178635 PECOS PAC ID: 6002728656 Enrollment ID: O20031103000220 |
News Archive
ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, and PHT Corporation, the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT.
Scientists at the University of Alberta have shown that the drug remdesivir is highly effective in stopping the replication mechanism of the coronavirus that causes COVID-19, according to new research published today in the Journal of Biological Chemistry.
Perrigo Company today announced that it has acquired rights to Novel Laboratories' pending ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets), indicated for the cleansing of the colon as a preparation for colonoscopy in adults.
Population aging could peak by 2040 in Germany and by 2070 in China, according to a new study published in the journal PLOS ONE, which combines new measures of aging with probabilistic population projections from the UN. In the USA, the study shows very little population aging at all in the coming century.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sahzene Yavuz, MD Po Box 13833, Philadelphia, PA 19101-3833 Ph: (352) 273-8656 | Sahzene Yavuz, MD 105 Desmond St, Sayre, PA 18840-2001 Ph: (201) 421-9520 |
News Archive
ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, and PHT Corporation, the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT.
Scientists at the University of Alberta have shown that the drug remdesivir is highly effective in stopping the replication mechanism of the coronavirus that causes COVID-19, according to new research published today in the Journal of Biological Chemistry.
Perrigo Company today announced that it has acquired rights to Novel Laboratories' pending ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets), indicated for the cleansing of the colon as a preparation for colonoscopy in adults.
Population aging could peak by 2040 in Germany and by 2070 in China, according to a new study published in the journal PLOS ONE, which combines new measures of aging with probabilistic population projections from the UN. In the USA, the study shows very little population aging at all in the coming century.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
› Verified 4 days ago
Dr. Premjeet Singh Dhillon, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-6666 | |
Dr. Michael Jon Depersis, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Square, Guthrie Medical Group, Sayre, PA 18840 Phone: 570-888-5858 | |
Dr. Joseph B. Blood, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 Fax: 570-887-2694 | |
Vishwa Kundoor, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-867-0962 | |
Dr. Jason Paul Kartis, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq Ste B, Sayre, PA 18840 Phone: 570-888-6666 | |
Dr. Victor Olaolu Kolade, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 |